Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Medical Devices & Mechanical Engineering
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Immundiagnostik AG has 4 pending office actions in Chemistry & Materials. These involve 4 distinct examiners and 3 distinct art units. GERIDO, DWAN A is the busiest examiner, managing 1 pending office action. The workload is spread across 4 distinct examiners, but shows slight concentration at the art unit level with only 3 distinct art units involved. This suggests some technical overlap among the 4 pending office actions.
Because the busiest examiner, GERIDO, DWAN A, only manages 1 pending office action, the outcomes of the 4 pending office actions will be determined independently by 4 distinct examiners. This structure requires a prosecution strategy that accounts for the varied expectations of the examiners while considering the internal guidelines of the 3 distinct art units. The 4 pending office actions represent a decentralized inventory where the success of one application is unlikely to be directly influenced by the others. Practitioners should analyze the tendencies of the 3 distinct art units to effectively manage the portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (50%) |
| Double-patenting + other | 1 (25%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GERIDO, DWAN A | 1 | 58.1% | +30.4% |
| XU, XIAOYUN | 1 | 59.9% | +31.6% |
| WESTFALL, SARAH ANN | 1 | 5.0% | +25.0% |
| GORDON, MELENIE LEE | 1 | 22.4% | +45.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18685728 | STOOL COLLECTION AND EXTRACTION SYSTEM FOR HUMAN MICROBIOM ANALYSIS | WESTFALL, SARAH ANN | 34d |
| 18610782 | METHOD OF MEASURING THE ENDOCYTIC VITAMIN D STATUS | GERIDO, DWAN A | — |
| 17795487 | TEST AND IN VITRO DIAGNOSIS OF IRRITABLE BOWEL SYNDROME | GORDON, MELENIE LEE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18685728 | STOOL COLLECTION AND EXTRACTION SYSTEM FOR HUMAN MICROBIOM ANALYSIS | WESTFALL, SARAH ANN | 34d |
| 18610782 | METHOD OF MEASURING THE ENDOCYTIC VITAMIN D STATUS | GERIDO, DWAN A | — |
| 18685753 | DIFFERENTIAL DIAGNOSIS OF HISTAMINE INTOLERANCE SYNDROME | XU, XIAOYUN | — |
| 17795487 | TEST AND IN VITRO DIAGNOSIS OF IRRITABLE BOWEL SYNDROME | GORDON, MELENIE LEE | — |
| Art Unit | Apps |
|---|---|
| 1797 | 2 |
| 3791 | 1 |
| 1651 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18610782 | METHOD OF MEASURING THE ENDOCYTIC VITAMIN D STATUS | GERIDO, DWAN A | 1797 | §101§102§103§112 | Non-Final OA | — | Pending | Mar 20, 2024 |
| 18685753 | DIFFERENTIAL DIAGNOSIS OF HISTAMINE INTOLERANCE SYNDROME | XU, XIAOYUN | 1797 | §103DP | Non-Final OA | — | Pending | Feb 22, 2024 |
| 18685728 | STOOL COLLECTION AND EXTRACTION SYSTEM FOR HUMAN MICROBIOM ANALYSIS | WESTFALL, SARAH ANN | 3791 | §103§112 | Final Rejection | 34d | Pending | Feb 22, 2024 |
| 17795487 | TEST AND IN VITRO DIAGNOSIS OF IRRITABLE BOWEL SYNDROME | GORDON, MELENIE LEE | 1651 | §101§103§112 | Non-Final OA | — | Pending | Jul 26, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialImmundiagnostik AG has 4 pending office actions as of October 2026, spread across 3 art units and 4 examiners.
Dwan A Gerido has the most, with 1 of Immundiagnostik AG's pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
